Highlights and Quick Summary
- Operating Cash Flow Growth for the quarter ending June 30, 2021 was -0.53 (a -159.88% decrease compared to previous quarter)
- Year-over-year quarterly Operating Cash Flow Growth decreased by -92.76%
- Annual Operating Cash Flow Growth for 2021 was 0.14 (a -98.69% decrease from previous year)
- Annual Operating Cash Flow Growth for 2021 was 10.7 (a 5190.71% increase from previous year)
- Annual Operating Cash Flow Growth for 2020 was 0.2 (a -77.25% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Cash Flow Growth of Biofrontera AG Sponsored ADR
Most recent Operating Cash Flow Growthof BFAGY including historical data for past 10 years.Interactive Chart of Operating Cash Flow Growth of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Operating Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | -0.53 | 0.14 |
| 2020 | – | – | – | 0.88 | 0.2 |
| 2019 | – | – | – | – | 0.04 |
| 2018 | – | – | – | – | 0.06 |
| 2017 | – | – | – | 0.34 | -0.03 |
| 2016 | -7.27 | – | – | – | 0.1 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic